安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Pharmaceutical Research Development | AbbVie
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives
- Patient Assistance - AbbVie
Find your medicine from this list of AbbVie treatments and review eligibility information for myAbbVie Assist Eligibility for myAbbVie Assist may be initiated through AbbVie Patient Access Support, which will review financial support opportunities for all AbbVie programs, including myAbbVie Assist
- Patients - AbbVie
From drug discovery and development to ensuring our medicines are accessible and affordable, patient needs are what guide our work We also create resources to help people taking our medicines feel empowered, informed and in control of their health, and we amplify their voices to ensure their concerns are heard and accounted for worldwide
- Patient Access and Affordability | AbbVie
AbbVie help patients get the medicines and solutions they need through various access and support programs and services, including saving cards, bridge programs and patient assistance programs that provide AbbVie medicines at no cost to eligible patients
- Products | AbbVie
Our products are approved in individual countries for specific uses and the information provided is governed by local regulations Product availability, name and indicated use may vary by country
- Device Management Portal - AbbVie
Simplifying the process for tracking, initiating warranty claims, and submitting product quality complaints or adverse events for select AbbVie products – including Eye care products marketed as Allergan, an AbbVie company and our Allergan Aesthetics portfolio
- AbbVie Completes Acquisition of Nimble Therapeutics
Acquisition adds potential novel oral peptide IL23R inhibitor for psoriasis as well as a peptide synthesis, screening and optimization platform to strengthen AbbVie's pipeline and R D capabilities
- AbbVie and ADARx Pharmaceuticals Announce Collaboration and License . . .
- Collaboration to leverage AbbVie's expertise in biotherapeutic drug development and commercialization together with ADARx's proprietary RNA technology to advance next-generation siRNA therapies across neuroscience, immunology and oncology
|
|
|